These 5 States To Receive Corona Drug

Hyderabad-based drug maker Hetero, which has approval to manufacture and market the generic version of the experimental COVID-19 drug Remdesivir, has sent 20,000 vials to five states including Maharashtra and Delhi - the two worst affected states in the country.

Gujarat and Tamil Nadu are the other two states that will receive the first batch of the drug which is being marketed under the brand name Covifor in India. Telangana's capital Hyderabad, where the drug maker is based, will also receive the first consignment.

Hetero said a 100-milligram vial of the drug will cost Rs 5,400. The company has set a target to produce one lakh vials of the drug in three-four weeks.

The next batch of the drug will be shipped to Kolkata, Indore, Bhopal, Lucknow, Patna, Bhubaneshwar, Ranchi, Vijayawada, Kochi, Trivandrum and Goa.

Currently, the drug is being manufactured at the company's formulation facility in Hyderabad. The active pharmaceutical ingredient (API) is being made in the firm's Visakhapatnam facility.